ctrl K

Price Alert

Belite Bio Inc (BLTE)

NASDAQ: BLTE · Real-Time Price · USD

62.41

0.60 (0.97%)

At close: Aug 20, 2025, 9:46 AM

Belite Bio Inc Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	31.68M	88.16M	42.09M	17.34M
Short-Term Investments	113.47M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	103K	166K	57K	823K
Receivables	594K	867K	19K	23K
Inventory	n/a	n/a	-19K	n/a
Other Current Assets	n/a	n/a	19K	n/a
Total Current Assets	147.07M	89.94M	42.81M	17.43M
Property-Plant & Equipment	965K	1.3M	1.38M	94K
Goodwill & Intangibles	3.99M	3.23M	31K	n/a
Total Long-Term Assets	5.06M	4.7M	1.47M	917K
Total Assets	152.13M	94.64M	44.27M	18.35M
Account Payables	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	308K	198K	n/a
Other Current Liabilities	992K	2.29M	1.33M	24K
Total Current Liabilities	6.05M	3.63M	2.1M	1.64M
Long-Term Debt	n/a	n/a	n/a	31.81M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	261K	578K	668K	31.81M
Total Liabilities	6.31M	4.21M	2.77M	33.44M
Total Debt	537K	886K	866K	31.81M
Common Stock	3K	3K	3K	1K
Retained Earnings	-107.65M	-71.5M	-39.87M	-27.22M
Comprehensive Income	-660K	-374K	-392K	-196K
Shareholders Equity	145.82M	90.43M	41.5M	-15.09M
Total Investments	113.47M	n/a	n/a	n/a